Editorial: Nitro-fatty acids: novel drug candidates for the co-treatment of atherosclerosis and nonalcoholic fatty liver disease

Curr Opin Lipidol. 2020 Apr;31(2):104-107. doi: 10.1097/MOL.0000000000000666.

Authors

Oren Rom¹, Yuhao Liu¹, Lin Chang¹, Y Eugene Chen¹, Michael Aviram²

Affiliations

¹ Department of Internal Medicine, Frankel Cardiovascular Center, University of Michigan Medical Center, Michigan, USA.
² The Lipid Research Laboratory, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Atherosclerosis / drug therapy*
Atherosclerosis / metabolism
Fatty Acids / chemistry
Fatty Acids / therapeutic use*
Humans
Non-alcoholic Fatty Liver Disease / drug therapy*
Non-alcoholic Fatty Liver Disease / metabolism

Substances

Fatty Acids

Grants and funding